Home/Filings/4/0001104659-22-063394
4//SEC Filing

deVries Tina Marie 4

Accession 0001104659-22-063394

CIK 0001739426other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:28 PM ET

Size

4.8 KB

Accession

0001104659-22-063394

Insider Transaction Report

Form 4
Period: 2022-05-18
deVries Tina Marie
EVP, Research & Development
Transactions
  • Tax Payment

    Ordinary Shares

    2022-05-18$1.40/sh5,447$7,626136,141 total

Issuer

RVL Pharmaceuticals plc

CIK 0001739426

Entity typeother

Related Parties

1
  • filerCIK 0001750589

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:28 PM ET
Size
4.8 KB